Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetails
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetailsHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreDetailsNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read moreDetails
Prime Minister Narendra Modi’s recent criticism of the Indian Foreign Service (IFS) was not merely an expression of frustration. It...
Read moreDetails
India is being shown in such a poor light that it does not stand comparison on the question of a...
Read moreDetails
Finally, the much-awaited biggest diplomatic breakthrough in the US-Israel war with Iran has been made with the US and Iran...
Read moreDetails
Kyiv saw a unique phenomenon recently when thousands of readers gathered at a literary festival defying air raids only to...
Read moreDetails
